Post by PPD

In this month's edition of Pipeline to Patient, Daniel Burch shares three takeaways from his recent conversation with Dr. Richard Pazdur on the future of oncology drug development.   "The future of oncology depends on balancing scientific rigor with innovation, patient-centeredness with pragmatism, and global collaboration with robust evidence generation," Burch writes.